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Abstract 
Inflammation and oxidative stress are believed to contribute to the pathology of 
several chronic diseases including hypercholesterolemia (elevated levels of 
cholesterol in blood) and atherosclerosis. HMG-CoA reductase inhibitors of plant 
origin are needed as synthetic drugs, such as statins, which are known to cause 
adverse effects on the liver and muscles. Amaranthus viridis (A. viridis) has been 
used from ancient times for its supposedly medically beneficial properties. In the 
current study, different parts of A. viridis (leaf, stem, and seed) were evaluated 
for potential anti-HMG-CoA reductase, antioxidant, and anti-inflammatory 
activities. The putative HMG-CoA reductase inhibitory activity of A. 
viridis extracts at different concentrations was determined spectrophotometrically 
by NADPH oxidation, using HMG-CoA as substrate. A. viridis leaf extract 
revealed the highest HMG-CoA reductase inhibitory effect at about 71%, with 
noncompetitive inhibition in Lineweaver-Burk plot analysis. The leaf extract 
showed good inhibition of hydroperoxides, 2,2-diphenyl-1-picrylhydrazyl (DPPH), 
nitric oxide (NO), and ferric ion radicals in various concentrations. A. viridis leaf 
extract was proven to be an effective inhibitor of hyaluronidase, lipoxygenase, 
and xanthine oxidase enzymes. The experimental data suggest that A. viridis leaf 
extract is a source of potent antioxidant and anti-inflammatory agent and may 
modulate cholesterol metabolism by inhibition of HMG-CoA reductase. 
